Global Gene Expression Analysis Market Projected to Show Strong Growth by 2026Posted by ganesha on December 24th, 2019 Global Gene Expression Analysis Market By Consumables (Reagents, DNA Chips), Technology (Polymerase Chain Reaction, Next-Generation Sequencing, DNA Microarray, Serial Analysis of Gene Expression, Northern Blotting), Application (Research, Drug Discovery, Diagnostics), Services (Gene Expression Profiling Services, Sequencing Services, Bioinformatics Solutions), End User(Pharmaceutical and Biotechnology Companies, Academic Institutes and Research Centers, Other) Market Definition: Global Gene Expression Analysis Market The gene expression is the method used for extracting data from a gene which will be used for the production of a practical gene product. With the help of gene expression, the genetic code reserved in DNA can be calculated. The research can be used for the classification of the diseases, which led its wide range of applications such as pharmacogenomics, diagnostics, biomarkers, and toxicology. FDA Cleared Roche Factor II, Factor V Gene Mutation Test for Inherited Thrombophilia. Factor V test for use on the Cobas 4800 system, which performs real-time PCR analysis for mid- to high-volume labs. Increasing application areas of gene expression act as a driver to the market growth. Market Drivers
Get Detailed ToC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-gene-expression-analysis-market Market Restraints
Market Analysis: Global Gene Expression Analysis Market Global Gene Expression Analysis Market is expected to rise from its initial estimated value of USD 4.18 billion by 2018 to an estimated value of USD 8.52 billion by 2026, registering a CAGR of 9.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the rise in the amount of cancer patients. Get Inquire Before Buying @ Segmentation: Global Gene Expression Analysis Market By Consumables
By Technology
By Application
By Services
By End User
Key Developments in the Market: In August 2018, Tianjin Novogene Bioinformatics Technology subsidiary of Novogene Co. received CFDA approval for its NovoFocus NSCLC CDx Test, this is a next-generation sequencing based diagnostic test that simultaneously analyzes tumor samples for multiple genomic mutations associated with several CFDA. In January 2017, Biorad announced the acquisition with RainDance Technologies, a droplet-based PCR systems manufacturer. RainDance Technologies has a more focused portfolio, primarily known for its droplet-based technologies for digital PCR (dPCR). Competitive Analysis: Global gene expression analysis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of gene expression analysis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: Sopan.gedam@databridgemarketresearch.com Report Related Global Mineral Supplements Market Like it? Share it! More by this author |